Tiziana Life Sciences Ltd Asset Resilience Ratio

Latest as of June 2019: 0.00%

Tiziana Life Sciences Ltd asset resilience ratio. Tiziana Life Sciences Ltd (TLSA) has an Asset Resilience Ratio of 0.00% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tiziana Life Sciences Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$2.10 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Tiziana Life Sciences Ltd (2000–2018)

Asset resilience ratio of Tiziana Life Sciences Ltd from 2000 to 2018. This chart shows how Tiziana Life Sciences Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Tiziana Life Sciences Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tiziana Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Tiziana Life Sciences Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Tiziana Life Sciences Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Tiziana Life Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare Tiziana Life Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
Biotechnology 10.35%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
SOLENO THERAPEUT. DL-001
F:6XC
Biotechnology 41.74%
89bio Inc
NASDAQ:ETNB
Biotechnology 71.60%
LegoChem Biosciences Inc
KQ:141080
Biotechnology 55.88%
DNA Link Inc
KQ:127120
Biotechnology 0.00%

Tiziana Life Sciences Ltd Asset Resilience Ratio by Year (2000–2018)

Tiziana Life Sciences Ltd asset resilience ratio by year from 2000 to 2018. The table below shows the annual Asset Resilience Ratio data for Tiziana Life Sciences Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2018-12-31 0.00% $0.00 $5.45 Million --
2015-12-31 0.00% $0.00 $9.25 Million --
2014-12-31 0.00% $0.00 $2.46 Million --
2002-12-31 20.90% $536.00K $2.56 Million +16.46pp
2000-12-31 4.44% $200.00K $4.50 Million --
pp = percentage points

About Tiziana Life Sciences Ltd

NASDAQ:TLSA USA Biotechnology
Market Cap
$72.52 Million
Market Cap Rank
#20361 Global
#4671 in USA
Share Price
$0.57
Change (1 day)
-6.65%
52-Week Range
$0.57 - $1.82
All Time High
$6.93
About

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes… Read more